NZ245244A - Preparation of tigogenin-; 11-ketotigogenin-, hecogenin-, and diosgenin-beta-0-cellobioside heptaalkanoate from the relevant steroid in the presence of zinc fluoride or cyanide - Google Patents

Preparation of tigogenin-; 11-ketotigogenin-, hecogenin-, and diosgenin-beta-0-cellobioside heptaalkanoate from the relevant steroid in the presence of zinc fluoride or cyanide

Info

Publication number
NZ245244A
NZ245244A NZ245244A NZ24524492A NZ245244A NZ 245244 A NZ245244 A NZ 245244A NZ 245244 A NZ245244 A NZ 245244A NZ 24524492 A NZ24524492 A NZ 24524492A NZ 245244 A NZ245244 A NZ 245244A
Authority
NZ
New Zealand
Prior art keywords
tigogenin
cellobioside
zinc
recited
hecogenin
Prior art date
Application number
NZ245244A
Other languages
English (en)
Inventor
Douglas J M Allen
Frank R Busch
John F Lambert
Russell J Shine
Stanley W Walinsky
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NZ245244A publication Critical patent/NZ245244A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NZ245244A 1991-11-25 1992-11-24 Preparation of tigogenin-; 11-ketotigogenin-, hecogenin-, and diosgenin-beta-0-cellobioside heptaalkanoate from the relevant steroid in the presence of zinc fluoride or cyanide NZ245244A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79757491A 1991-11-25 1991-11-25

Publications (1)

Publication Number Publication Date
NZ245244A true NZ245244A (en) 1995-04-27

Family

ID=25171219

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ245244A NZ245244A (en) 1991-11-25 1992-11-24 Preparation of tigogenin-; 11-ketotigogenin-, hecogenin-, and diosgenin-beta-0-cellobioside heptaalkanoate from the relevant steroid in the presence of zinc fluoride or cyanide

Country Status (13)

Country Link
EP (1) EP0619822A1 (enrdf_load_stackoverflow)
JP (1) JPH0826064B2 (enrdf_load_stackoverflow)
AU (1) AU659506B2 (enrdf_load_stackoverflow)
CA (1) CA2123684A1 (enrdf_load_stackoverflow)
FI (1) FI942394A0 (enrdf_load_stackoverflow)
HU (1) HUT67035A (enrdf_load_stackoverflow)
IL (1) IL103797A0 (enrdf_load_stackoverflow)
MX (1) MX9206761A (enrdf_load_stackoverflow)
NZ (1) NZ245244A (enrdf_load_stackoverflow)
PT (1) PT101088A (enrdf_load_stackoverflow)
TW (1) TW232699B (enrdf_load_stackoverflow)
WO (1) WO1993011150A1 (enrdf_load_stackoverflow)
ZA (1) ZA929081B (enrdf_load_stackoverflow)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2139104A1 (en) * 1992-06-26 1994-01-06 Michael P. Deninno Steroidal glycosides for treating hypercholesterolemia
NZ252006A (en) * 1992-06-26 1995-10-26 Pfizer Preparation of 1-o-steroidal peracyl-beta-glycosides
WO1994000478A1 (en) * 1992-06-26 1994-01-06 Pfizer Inc. Steroidal beta-o-cellobioside heptaalkanoate process
EP0696292A1 (en) * 1993-04-28 1996-02-14 Pfizer Inc. Spirostanyl glycosidal crystalline monohydrate
US5502038A (en) * 1993-06-21 1996-03-26 Medical Research Foundation Of Oregon Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption
EP0737202A1 (en) * 1993-12-28 1996-10-16 Pfizer Inc. Hypocholesterolemic agents
US6150336A (en) * 1995-05-29 2000-11-21 Pfizer Inc. Steroidal glycosides
US5756470A (en) * 1996-10-29 1998-05-26 Schering Corporation Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
SI1355644T1 (sl) 2001-01-26 2006-10-31 Schering Corp Uporaba substituiranih azetidinonskih spojin za zdravljenje sitosterolemije
ES2290562T3 (es) 2001-01-26 2008-02-16 Schering Corporation Combinaciones del activador del receptor activado por el proliferador de los peroxisomas (ppar) fenofibrato con el inhibidor de la absorcion de esteroles ezetimiba para indicaciones vasculares.
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
PT1429756E (pt) 2001-09-21 2007-01-31 Schering Corp Tratamento de xantoma com derivados de azetidinona como inibidores de absorção de esteróis
MXPA05004811A (es) 2002-11-06 2005-07-22 Schering Corp Inhibidores de absorcion de colesterol para el tratamiento de trastornos autoinmunes.
ES2311806T3 (es) 2003-03-07 2009-02-16 Schering Corporation Compuesto de azetidinona sustituidos, fornulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JP4589919B2 (ja) 2003-03-07 2010-12-01 シェーリング コーポレイション 高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用
WO2004081004A1 (en) 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602005A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis
US4602003A (en) * 1982-05-17 1986-07-22 Medical Research Foundation Of Oregon Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia

Also Published As

Publication number Publication date
MX9206761A (es) 1995-01-31
FI942394A7 (fi) 1994-05-24
FI942394L (fi) 1994-05-24
FI942394A0 (fi) 1994-05-24
HUT67035A (en) 1995-01-30
TW232699B (enrdf_load_stackoverflow) 1994-10-21
JPH06510794A (ja) 1994-12-01
JPH0826064B2 (ja) 1996-03-13
AU2775892A (en) 1993-06-28
IL103797A0 (en) 1993-04-04
ZA929081B (en) 1994-05-24
HU9401374D0 (en) 1994-08-29
PT101088A (pt) 1994-02-28
EP0619822A1 (en) 1994-10-19
CA2123684A1 (en) 1993-06-10
AU659506B2 (en) 1995-05-18
WO1993011150A1 (en) 1993-06-10

Similar Documents

Publication Publication Date Title
NZ245244A (en) Preparation of tigogenin-; 11-ketotigogenin-, hecogenin-, and diosgenin-beta-0-cellobioside heptaalkanoate from the relevant steroid in the presence of zinc fluoride or cyanide
US5939398A (en) Hypocholesterolemic agents
US5698526A (en) Steroidal glycosides
US6150336A (en) Steroidal glycosides
Mattox et al. Synthesis of C-21 glucosiduronates of cortisone and related corticosteroids
US5530107A (en) Method for making steroidal peracyl glycosides
US5563259A (en) Process for making β-O-cellobiosyl steroid derivatives and trimethyl silyl steroid intermediates used therein
EP1558627B1 (en) Stereospecific reduction of sapogen-3-ones
EP0044227B1 (en) 11-alpha-amino androstanes, pharmaceutical compositions containing them and processes for their preparation
EP0647235B1 (en) Process for steroidal peracyl glycosides
US4413120A (en) Process for producing acosamine, daunosamine, 1-thioacosamine and related compounds
JPH08208688A (ja) ジンセノサイドRh2の製造方法
EP0066467B1 (en) 11-alpha-amino-androstanes
JPH03264595A (ja) 新規なグリコシル化方法
JP2984406B2 (ja) ステロイド誘導体の製造法
US2960512A (en) Process for the preparation of 8 (14)-unsaturated-9-alkoxy-11-hydroxy steroid compounds
US20110054156A1 (en) Synthesis of timosaponin bii
WO2005005454A1 (en) Steroid modified chacotrioses and solatrioses
Ojeda et al. α, β-D-Glucopyranose and 2-Azido-4, 6-O-Benzylidene-2-Deoxy-α, β-D-Glucopyranose
US20090012013A9 (en) Steroid modified solatrioses
Ojeda et al. Ricardo Lucas, Niels Reichardt, Lin Liu, and Manuel Martín-Lomas